A drug created and manufactured by Advancer Enterprises, it entered Advancer's pharmaceutical catalog in late YE 45. Gailicaine is a potent, fast-acting sedative primarily used in the medical field to prepare patients for surgery. It's known for its ability to rapidly induce a state of sedation with minimal memory loss.
»Optional Image« | |
Year Created: | YE 45 |
Designer / Manufacturer: | Advancer Enterprises |
Nomenclature: | AE-N26 |
Price: | 20 KS per 3ml vial |
Gailicaine was conceived as part of Advancer Enterprises' commitment to revolutionizing anesthesia and sedation. The company recognized the need for a sedative that could act quickly without causing significant memory loss. After rigorous R&D and clinical trials, Gailicaine was added to their catalog in YE 45.
Gailicaine works by depressing the central nervous system, thereby reducing anxiety, inducing sleep, and causing a loss of consciousness if necessary. Unlike other sedatives, Gailicaine's effects are remarkably rapid, making it the drug of choice in situations requiring quick sedation. A significant advantage of Gailicaine is that it causes minimal loss of memory up to the point of sedation, allowing patients to recall instructions or information given prior to the procedure.
The standard dose of Gailicaine, particularly in its gaseous form, is carefully calibrated based on a variety of factors including the patient's weight, age, and medical history. In a controlled medical setting, a typical dose might range from 1-3ml of vaporized Gailicaine per kilogram of body weight. This dosage is administered via inhalation and should only be conducted under strict medical supervision to mitigate risks of overdose or adverse reactions.
While Gailicaine is generally well-tolerated, it can cause some side effects, including dizziness, dry mouth, and in some cases, a hangover effect post-surgery. Also, Gailicaine's metabolites are harmful to the liver if used excessively within a short time frame. Therefore, its use should be carefully managed, especially in patients with pre-existing liver conditions.
An overdose of Gailicaine can result in severe respiratory depression and acute liver failure. The overdose threshold is estimated to be between 15ml to 30ml, depending on the patient's weight and liver function. Immediate medical intervention is imperative, often involving respiratory support, liver dialysis, and the administration of reversal agents.
Demibear created this article on 2023/10/09 23:53.
Approval Thread: https://stararmy.com/roleplay-forum/threads/advancer-enterprises-white-lion-type-45-vehicle-aid-kit.71051/
Star Army Logistics | |
---|---|
Supply Classification | Class J - MEDICAL BIOLOGICAL |
Drugs, Medicines, and Pharmaceuticals | |
---|---|
Drug Name(s) | Gailicaine |
Route of Administration | mouth inhalation, intravenous (IV) |
Drug Class | Anesthetics, Sedative |
Products & Items Database | |
---|---|
Product Categories | drugs |
Product Name | Gailicaine |
Nomenclature | AE-N26 |
Manufacturer | Advancer Enterprises |
Year Released | YE 45 |
Price (KS) | 20.00 KS |